Mirtazapine in suicidal Huntington's disease [1]

Annals of Pharmacotherapy

Volumn 37, Issue 3, 2003, Pages 452-

  Bonelli, Raphael M ^a  

^a Hospital BHB Eggenberg   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

MIRTAZAPINE;

ADULT; CASE REPORT; DEPRESSION; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HIGH RISK POPULATION; HUMAN; HUNTINGTON CHOREA; LETTER; PRIORITY JOURNAL; SIDE EFFECT; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT; TREATMENT OUTCOME;

EID: 0037372769     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1C352     Document Type: Letter

References (6)

1. Morris M, Scourfield J. Psychiatric aspects of Huntington's disease. In: Harper PS, ed. Huntington's disease. 2nd ed. London: Saunders, 1996:73-121.
2. Folstein SE. Huntington's disease: a disorder of families. Baltimore, MD: Johns Hopkins University Press, 1989.
3. Huntington G. On chorea. Med Surg Rep 1872;26:317-21.
4. Farrer LA. Suicide and attempted suicide in Huntington's disease: implications for preclinical testing of persons at risk. Am J Med Genet 1986;24(2):305-11.
5. Lipe H, Schultz A, Bird TD. Risk factors for suicide in Huntington's disease: a retrospective case controlled study. Am J Med Genet 1993;48(4):231-3.
6. Arciniegas DB, Anderson CA. Suicide in neurologic illness. Curr Treat Options Neurol 2002;4:457-68.